We are pleased to announce that the U.S. Food and Drug Administration (FDA) amended Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

This is a very common question, so let’s get straight to it.

With support from the Cross-Border Threat Screening and Supply Chain Defense Center of Excellence, Biomeme and Predigen were proud to recently...

We are proud to announce our new SARS-CoV-2 Mutation Panel 1.0 (RUO) to help researchersepidemiologists, and local, state, and federal health...

Biomeme has officially outgrown its home at 10th and Chestnut and is moving on to Netrality’s 401 North Broad Street for its new corporate...

As the world crosses the 1-year mark since the World Health Organization classified COVID-19 as a pandemic, testing is still as crucial as ever....

The Partnership

Back in May 2019, Biomeme and INDICAL Bioscience entered into an exclusive global licensing and research agreement in a joint...

We are thrilled to announce Biomeme, Inc. has been awarded a Redevelopment Assistance Capital Program (RACP) grant of $3 million from the...

List of SARS-CoV-2 Variants & Classifications

Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates...